For patients with chronic kidney disease, long-term hemodialysis represents a risk factor for HCV exposure1,2. In these patients with CKD that go on to develop a chronic HCV infection, HCV has been associated with an accelerated progression of renal disease and with increased morbidity and mortality in these patients3.
In this program, Dr. Mathew Weir, Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital, Baltimore, is joined by Dr. David Roth, Professor of Nephrology and Clinical Director of the Katz Family Division of Nephrology and Hypertension at the University of Miami Miller School of Medicine to discuss HCV risk factors, screening, diagnosis and management of HCV in patients with CKD.
- CDC. Hepatitis C FAQs for Health Professionals. Available at: https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm. Accessed June 2017.
- AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. Available at: http://www.hcvguidelines.org. Accessed June 2017.
- Molnar M, et al. Hepatology. 2015;61:1495–502.
This module is intended for United States and Puerto Rico health care professionals only and was developed by AbbVie.